Evidence map›Paper›PMID 42639554›Full record

ArticleNanoscale advances2026

Beta-cyclodextrin-based polymerized nanocarriers for doxorubicin delivery to cancer cells.

Maryam Aslam, Muhammad Shahid Nazir, Asima Asghar, Arsalan Ahmed, Hamza Anjum, Fakhera Ikram, Asma Jaffer, Anila Asif

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanoscale advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Maryam AslamInterdisciplinary Research Centre in Biomedical Materials, COMSATS University Islamabad, Lahore Campus Lahore Pakistan arsalanahmed@cuilahore.edu.pk +92 316 3068269.
Muhammad Shahid NazirDepartment of Chemistry, COMSATS University Islamabad, Lahore Campus Lahore Pakistan.
Asima AsgharInterdisciplinary Research Centre in Biomedical Materials, COMSATS University Islamabad, Lahore Campus Lahore Pakistan arsalanahmed@cuilahore.edu.pk +92 316 3068269.
Arsalan AhmedInterdisciplinary Research Centre in Biomedical Materials, COMSATS University Islamabad, Lahore Campus Lahore Pakistan arsalanahmed@cuilahore.edu.pk +92 316 3068269.ORCID https://orcid.org/0000-0003-4099-0101
Hamza AnjumShalamar Medical and Dental College Lahore Pakistan.
Fakhera IkramInterdisciplinary Research Centre in Biomedical Materials, COMSATS University Islamabad, Lahore Campus Lahore Pakistan arsalanahmed@cuilahore.edu.pk +92 316 3068269.
Asma JafferInterdisciplinary Research Centre in Biomedical Materials, COMSATS University Islamabad, Lahore Campus Lahore Pakistan arsalanahmed@cuilahore.edu.pk +92 316 3068269.
Anila AsifInterdisciplinary Research Centre in Biomedical Materials, COMSATS University Islamabad, Lahore Campus Lahore Pakistan arsalanahmed@cuilahore.edu.pk +92 316 3068269.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In-depth drug penetration is significant for achieving optimal therapeutic effects; particularly, anticancer drugs must penetrate deep into tumours to exert toxic effects on cancer cells. Drug-loaded nanocarriers are promising for targeted drug delivery. However,

Identifiers

PMID42639554
PMCPMC13502243

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.